Enzo Biochem Stock

Enzo Biochem Dividend

Delisted·Apr 17, 2025

The Dividend of Enzo Biochem (ENZ) as of Aug 14, 2026 is 0.10 USD.

Dividend

0.10USD

Dividend yield

31.87 %

Last updated:

How much dividend does Enzo Biochem 2026 pay?

According to the latest status from August 2026, Enzo Biochem paid a total of 0.10 USD per share in dividends within the last 12 months. With the current Enzo Biochem price of 0.31 USD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 31.87%.

Historical Enzo Biochem Dividends

PaydateDividend
12/15/20240.10USD

Is the Enzo Biochem Dividend Safe?

Enzo Biochem has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Enzo Biochem dividend payout ratio

In 2025, Enzo Biochem had a payout ratio of 0.00%. The payout ratio indicates the percentage of the company's profits that Enzo Biochem distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
0.00 %
Jan 1, 2021
0.00 %
Jan 1, 2022
0.00 %
Jan 1, 2023
0.00 %
Jan 1, 2024
-200.00 %
Jan 1, 2025 (e)
0.00 %
Jan 1, 2026 (e)
0.00 %
Jan 1, 2027 (e)
0.00 %

Dividend Details

Understanding Enzo Biochem's Dividend Distributions

Enzo Biochem’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Enzo Biochem's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Enzo Biochem's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Enzo Biochem’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Enzo Biochem Stock analysis

What does Enzo Biochem do? Enzo Biochem Inc is a US-based company operating in the biotechnology sector. It was founded in 1976 by Elazar Rabbani and is headquartered in New York. The company focuses on developing, producing, and marketing innovative diagnostic and therapeutic products for the medical industry. Enzo Biochem Inc's business model is based on the application of modern technologies for the development and synthesis of molecules for medical technology and life sciences. At the same time, the company also offers diagnostic testing systems and clinical laboratory services to its customers. Enzo Biochem's business model is therefore diverse and covers various areas. Enzo Biochem divides its business into three main segments: life sciences, clinical labs, and therapeutics. In the life sciences segment, the company engages in research and development of technologies for synthesizing molecules for medical technology. In the clinical labs segment, Enzo Biochem offers diagnostic testing systems and clinical laboratory services for use in medical diagnostics. The therapeutics segment manufactures therapeutic products for the treatment of viral infections. Enzo Biochem's product offering includes a wide range of products and services. This includes molecules for medical technology, diagnostic testing systems, and therapy products for viral infections. The product lines of Enzo Biochem include: - Molecules for medical technology: Enzo Biochem has developed a wide range of molecules for medical technology and is a leader in this field. These molecules include proteins, antibodies, and other biomolecules. The company also offers custom molecules for specific applications. - Diagnostic testing systems: The company offers a wide range of diagnostic testing systems tailored to the needs of laboratories and clinics. The tests include tests for infectious diseases, cancer, metabolic disorders, and other diseases. - Clinical laboratory services: Enzo Biochem provides a wide range of clinical laboratory services, including blood tests, microbiological tests, urine, stool, and body fluid tests, as well as histological analysis of tissue samples. - Therapy products: Enzo Biochem has developed a broad portfolio of therapy products for the treatment of viral infections. These products include immunomodulators, antivirals, and other therapeutics aimed at combating various pathogens. Enzo Biochem has made a name for itself in the biotechnology industry through continuous innovation and high-quality products. The company has also engaged in partnerships, acquisitions, and joint ventures to expand its global footprint. It has a global presence and works with leading pharmaceutical and biotech companies from around the world. Overall, Enzo Biochem has established itself as a leading biotechnology company operating in the fields of life sciences, clinical labs, and therapeutics. The company offers a wide range of products and services tailored to the needs of laboratories and clinics. Enzo Biochem has established itself as an innovation leader in the biotechnology industry and is committed to further expanding its business through the development of new products and technologies. Enzo Biochem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enzo Biochem stock

The current dividend yield of Enzo Biochem is 31.87 %.

Enzo Biochem paid dividends every year for the past 0 years.

Enzo Biochem is assigned to the 'Health' sector.

To receive the latest dividend of Enzo Biochem from amounting to 0.1 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Enzo Biochem distributed 0.1 USD as dividends.

The dividends of Enzo Biochem are distributed in USD.

Dividend calendar 2026
Access this data via the Eulerpool API

All Key Metrics — Enzo Biochem